Bipartisan group of US lawmakers calls for export controls on synthetic DNA sequences

A bipartisan group of U.S. lawmakers this week introduced bills that would require U.S. firms to obtain a license before ...

Antibody formulation could enable simple injections instead of lengthy hospital infusions

Antibody treatments for cancer and other diseases are typically delivered intravenously, because of the large volumes that are needed per dose. This means the patient has to go to a hospital for every ...

Biphenomycin biosynthetic pathway decoded, opening door to new antibiotic development

Biphenomycins, natural products derived from bacteria, show excellent antimicrobial activity, but have long remained out of ...
UC San Diego Today

Scientists Uncover Key Driver of Treatment-Resistant Cancer

UC San Diego scientists discover enzyme responsible for scrambling cancer genomes; results could enable new treatments for ...

GC Biopharma Ships First Doses of World's First Recombinant Anthrax Vaccine, 'BARYTHRAX inj.'

First anthrax vaccine developed using recombinant DNA technology- Annual production capacity of up to 10 million doses at GC ...

Peptide Therapeutics Market Size to Reach USD 82.19 Billion by 2032; Surging Requirements for Targeted Medicines in Oncology Augment Market Expansion - SNS Insider

According to Research by SNS Insider, the U.S. Peptide Therapeutics Market is Set to Reach USD 35.71 Billion by 2032, Supported by Rising Adoption of Precision Biologics and Advances in Peptide ...